ARTICLE | Financial News
Pacira sets IPO range
January 14, 2011 12:43 AM UTC
Pacira Pharmaceuticals Inc. (Parsippany, N.J.) amended its IPO and hopes to sell 4.3 million shares at $14-$16. A $15 price would raise $63.8 million and value the company at $223.7 million. The offering is underwritten by Barclays Capital; Piper Jaffray; Wedbush PacGrow Life Sciences; and Brean Murray, Carret & Co. ...